Trial intelligence / Profile preview

Comparison of Mesotherapy Treatment Doses in Patients With Chronic Non-Specific Neck Pain

NCT07462988Completed

Sponsor
Istanbul Medeniyet University
Start
Jan 2025
Primary completion
Jun 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of lidocaine and meloxicam in Cervicalgia (4 arms), sponsored by Istanbul Medeniyet University. Primary endpoint: Visual Analogue Scale at 12 weeks. Started Jan 2025; status: completed.

02

Drugs

lidocainemeloxicam
03

Conditions

Cervicalgia

Beyond the preview

Go deeper on NCT07462988.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07462988.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call